Globe Life (NYSE:GL) Stock Gets Price Target Trim from TD Cowen

Globe Life (NYSE:GL) had its target price cut by TD Cowen from $225.00 to $215.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the stock.

Other research analysts have also recently issued research reports about the stock. Morgan Stanley lowered their target price on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a report on Monday, October 5th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday. Wells Fargo & Company lifted their price target on shares of Globe Life from $190.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $193.00 to $195.00 and gave the company an “overweight” rating in a research report on Thursday, October 15th. Finally, Jefferies Financial Group upped their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $182.60.

Globe Life Stock Performance

Shares of GL opened at $154.62 on Friday. The stock has a 50 day moving average price of $169.95 and a 200 day moving average price of $167.33. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $11.88 billion, a price-to-earnings ratio of 10.34 and a beta of 0.44. Globe Life has a 52-week low of $127.85 and a 52-week high of $191.55.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $4.84 EPS for the quarter, missing the consensus estimate of $4.90 by ($0.06). Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The company had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the company earned $4.81 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Research analysts predict that Globe Life will post 15.61 EPS for the current fiscal year.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s payout ratio is 8.83%.

Globe Life declared that its board has approved a stock repurchase program on Monday, August 10th that permits the company to buy back $2.50 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 17.7% of its shares through open market purchases. Share buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Insider Transactions at Globe Life

In other news, EVP Robert Hensley sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the transaction, the executive vice president directly owned 12,384 shares in the company, valued at approximately $2,106,146.88. This trade represents a 44.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO James Darden sold 50,000 shares of the firm’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the transaction, the chief executive officer directly owned 58,451 shares in the company, valued at $10,663,215.93. The trade was a 46.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 143,650 shares of company stock worth $25,793,717 in the last three months. Corporate insiders own 2.11% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Johnson Financial Group Inc. acquired a new stake in shares of Globe Life during the second quarter worth about $39,000. AdvisorNet Financial Inc increased its position in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the period. Fortitude Family Office LLC increased its position in Globe Life by 94.6% in the 3rd quarter. Fortitude Family Office LLC now owns 327 shares of the company’s stock valued at $54,000 after acquiring an additional 159 shares during the period. Assetmark Inc. increased its position in Globe Life by 42.0% in the 2nd quarter. Assetmark Inc. now owns 426 shares of the company’s stock valued at $76,000 after acquiring an additional 126 shares during the period. Finally, Root Financial Partners LLC raised its stake in Globe Life by 23.3% during the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after acquiring an additional 83 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life projected 2027 adjusted earnings of $16.10–$17.10 per share, with the midpoint modestly above the current consensus estimate of $16.51. Management also targeted $850 million–$950 million in parent excess cash flow, supporting potential capital returns. Globe Life projects 2027 EPS and excess cash flow
• Positive Sentiment: TD Cowen maintained a Buy rating, although it reduced its price target from $225 to $215. The revised target still implies substantial potential upside based on the referenced share price. TD Cowen price target update
• Neutral Sentiment: Management’s 2027 EPS guidance range spans $16.10–$17.10, indicating continued growth potential but also a relatively wide range of outcomes. The company’s quarterly revenue and investment income benefited from growth in premiums and investments. Globe Life earnings guidance
• Negative Sentiment: Globe Life reported third-quarter EPS of $4.84, below analyst expectations near $4.87–$4.90. Weaker underwriting income, rising expenses and a reported $6.4 million underwriting loss offset higher premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life lowered its 2026 EPS guidance to $15.35–$15.65, below the $15.72 consensus estimate. The weaker outlook was linked in part to losses at Evry Health, increasing concerns about profitability and execution. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded Globe Life, arguing that the stock is no longer a “predictable safe haven” following the earnings release. The downgrade adds pressure to investor sentiment after the earnings miss and guidance reduction. Piper Sandler downgrades Globe Life

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.